“…Because, high doses of FSH may induce changes in ovarian and/or endocrine dynamics (Kafi & McGowan, ) and on LH pulses, increasing the incidence of PRCL (Bevers, Dieleman, Blankestein, Tol, & Broek, ; Oliveira et al, ) besides being more expensive (Loiola Filho et al, ). Furthermore, higher doses may maintain the stimulus of the luteinized anovulatory follicles for longer periods, so these follicles are still producing oestrogen in the early luteal phase, causing persistence of high concentrations of this hormone, providing the early release of PGF2α and thus premature luteal regression (Okada et al, ).…”